Anjali Modi

Dr. Anjali Modi

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
AMAnjali Modi
Anjali Modi
SGSukesha Gamit
Sukesha Gamit
BJBharat S. Jesalpura
Bharat S. Jesalpura
GKGeorge Kurien
George Kurien
JKJayendra K. Kosambiya
Jayendra K. Kosambiya
Following the World Health Assembly resolution on Elimination of lymphatic filariasis (ELF) as a public health problem by the year 2020, a Global Program (GPELF) was launched in 1997 to help endemic countries to initiate national programs. The current strategy to interrupt transmission of LF, is administration of once-yearly, single-dose, two-drug regimen (Albendazole with Diethylcarbamazine (DEC) to be used in endemic areas with the goal of reaching 65% epidemiological coverage for 4–6 years. We report findings of independent assessment from year 2010 to 2015 for last six rounds, after initial five rounds of Mass Drug Administration (MDA) since 2005 for ELF in endemic area of Gujarat. Independent assessment of MDA was performed to find coverage and compliance indicators, reasons for non-coverage and non-compliance in five Implementation Units (IUs). Pre, during and post MDA evaluations were done in three phases. The impact of MDA was measured by microfilaraemia survey. A total of eight sites, four random and four fixed sentinel sites were selected to calculate microfilaria rate (MF) per IUs per year. In years 2010 to 2015, we report results from 125,936 nocturnal blood smears and 17551 population in 120 selected clusters. Four clusters were selected per year in each of the five IUs for assessment of MDA round. Post MDA survey showed drug coverage between 81%-88% and epidemiological coverage 77%-89% across years. Main reasons for non-coverage were drug administrator related (the team did not visit or missed people) while non-compliance was population related (fear of side effects, sickness, people forgot or absent). During MDA findings show that the directly observed consumption is considerably improved from 58% in 2010 to 82% in 2015. The knowledge about benefits of drug provided also increased from 59% to 90% over the years. The current MF rate is less than one in all IUs with an overall 68% percent decrease from baseline year 2005 to year 2015. The average MF rate of Gujarat is 0.44 for year 2015. The findings show that achieving adequate epidemiological and drug coverage is possible by actual field level operation of the program in large endemic areas. The results and feedback from independent assessment, performed regularly, could guide the policymakers and program managers for mid-term corrections and to frame strategies to enhance program. Monitoring of coverage and impact indicator together informs decisions for reaching end-point of MDA. The impact indicator- microfilaria rate in all IUs of South Gujarat Region has reached and remained less than one percent signaling end-points of MDA. Post MDA stringent monitoring in form of TAS is recommended to keep vigil on maintenance of elimination achieved. The Global Program to Eliminate Lymphatic Filariasis (GPELF) is one of the largest public health intervention till date based on mass drug administration (MDA). MDA interrupts transmission by clearing larval parasites from blood so that they are unavailable for mosquitoes. The current communication describes independent assessment of annual MDA of diethylcarbamazine and albendazol in endemic area of Gujarat state, India during years 2010–2015. The process indicators coverage and compliance rates and impact indicator microfilaraemia were studied following WHO guidelines. We report results from 125,936 nocturnal blood smears and 17,551 population in 120 clusters. Post MDA survey shows high coverage and compliance above 85%. Both drug and epidemiological drug coverage were above recommended average of 80% and 65% respectively. Directly observed consumption improved from 58% in 2010 to 82% in 2015. The reports were shared with program managers and drug administrators to inform development of specific strategies to enhance the program. Microfilaraemia decreased by 68% from baseline year 2005 to 2015. Findings demonstrate implementing MDA gives sustainable results in large populations. After ten rounds MDA, LF transmission is interrupted and microfilaraemia decreased to <1%. Now, Gujarat State is ready for post-MDA surveillance and Transmission Assessment Survey (TAS).

18 May 2021 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
AMAnjali Modi
Anjali Modi
KVKeshav G. Vaishnav
Keshav G. Vaishnav
KKKailash Kothiya
Kailash Kothiya
NANeal Alexander
Neal Alexander
Background: To secure the gains of lymphatic filariasis (LF) elimination programs, attention is needed to the ‘residual microfilaremia phase’, in which high-risk populations may be crucial. The present study documents the impact of mass drug administration (MDA) in the urban Indian setting of Surat City, with high rates of in-migration. Methods: Epidemiological assessment included National Filaria Control Program (NFCP) and World Health Organization recommended routine and pre-MDA microfilaremia surveys respectively. Routine filaria surveys were conducted around the year in approximately 2000–4000 people per month, while pre-MDA surveys were carried out annually among approximately 4000 people from four fixed and four random sites. In 2016, Transmission Assessment Survey (TAS) was done in primary school children. The outcomes were microfilaremia (Mf) and antigen prevalence; more specifically, microfilaremia according to place of birth, in pre-MDA and routine night blood smears (NBS) collected from 2008 to 2015. Prevalence ratios and confidence intervals were calculated. Results: A total of 25 480 pre-MDA and 306 198 routine NBS were examined during the study. In 2008, the Mf prevalence in the routine survey was 63/18 814 (0.33%), declining to 23/39 717 (0.06%) in 2016. Pre-MDA surveys showed a similar decrease from 47/4184 (1.1%) in 2008 to 12/4042 (0.3%) in 2015. In those born outside Surat, microfilaremia decreased below transmission thresholds, but remained more than treble that of the remainder of the population, in both the pre-MDA surveys [prevalence ratio: 3.17, 95% confidence interval (CI): 1.15–8.72], and the routine surveys (3.31, 95% CI: 1.47–7.48). Though the TAS results indicated that MDA endpoints had been reached, sub-group analysis identified that 90% of antigenemic children were from families of high-risk groups. Conclusions: Extensive long-term epidemiological monitoring suggests that all the urban population, including high-risk groups, have benefitted from the ELF program. To prevent re-establishment of infection in large urban areas with unsanitary conditions conducive to filarial vector breeding, there is need to identify residual microfilaremia by customized surveys in addition to pre-MDA monitoring and TAS. The present findings can be used to develop strategies to prioritize screening, surveillance and plan treatment of high-risk groups after achieving MDA endpoints.

AMAnjali Modi
Anjali Modi
CACristian Garcia Alcaraz
Cristian Garcia Alcaraz
STSangita Trivedi
Sangita Trivedi
JKJ. K. Kosambiya
J. K. Kosambiya
KWKristen Wells
Kristen Wells
With ten percent of the world’s children living with Human Immunodeficiency Virus (HIV/ AIDS) in India, achieving elimination of parent/mother to-child transmission (EPTCT/EMTCT) is far away. Timely initiation and optimal adherence to the prevention of parent/mother to child transmission (PPTCT/PMTCT) may reduce new paediatric HIV infections to zero. This qualitative study applies the Socio-ecological Model (SEM) to understand country, region and context-specific factors influencing mothers’ engagement in the PMTCT care continuum. Maximum variation sampling and saturation tenets determined the sample size. An in-depth interview guide based on SEM “a priori” and emerging themes captured narratives of the parental dyad. The translated and transcribed audio records were coded by direct content analysis method, both manually and with Atlas Ti software. The coding reports were discussed for consensus and final analysis. Male partner, peers, community health workers (CHWs), hope for healthy baby, knowledge about HIV and preventive services, free anti-retroviral therapy, transportation and the early infant diagnosis (EID) tool influenced PMTCT care continuum. Testing and referral policies of the private sector facilitated internalized or self-stigma. Future interventions should seek to develop pregnant women’s support system by engaging male partners, peers, and CHWs. Strategies addressing private sector and community awareness about freely available HIV prevention and care programs may enable optimal PMTCT utilization.

1 January 2019 in Indian Journal of Community Medicine
Verified
Journal Article
Open access
PDF file
AMAnjali Modi
Anjali Modi
JKJayendrakumar K Kosambiya
Jayendrakumar K Kosambiya
STSangita Trivedi
Sangita Trivedi
VCVipul P Chaudhari
Vipul P Chaudhari
AMAlap Mehta
Alap Mehta
KWKristen J Wells
Kristen J Wells
Background: India has the third largest human immunodeficiency virus (HIV) epidemic in the world, with 15,000 newborns infected every year. Prevention of mother-to-child transmission (PMTCT) services can eliminate new HIV infections. Nondisclosure of positive HIV status and nonoptimal uptake of PMTCT are related. Therefore, understanding different aspects of HIV disclosure are necessary for program managers and careproviders for prevention and support. Objective: The present research explores HIV disclosure narratives, the family's perspective, and theoretical framework in the context of PMTCT. Methods: A qualitative study was conducted among 31 (16 mothers and 15 fathers) utilizers of PMTCT at an urban antiretroviral therapy center. A semi-structured in-depth interview guide based on disclosure process model (DPM) was used to explore HIV disclosure goals and outcomes by both members of parental dyad. The recorded interviews were transcribed verbatim, translated into English, and analyzed with Atlas.ti software. Directed content analysis was used to code data according to “a priori” and emerging themes. Demographic data were analyzed using descriptive statistics. Results: Limited disclosure is a necessity for pregnant women and their male partners for approach coping with HIV diagnosis and pursuing positive support for PMTCT adherence. Interpersonal, society, and community contextual outcomes affect the care uptake and future likelihood of disclosure. Conclusions: DPM suggestions from the present study can be used to facilitate a goal-directed process that allows parents/PLWHA to selectively disclose their HIV status to family members and acquaintances for obtaining maximum support to eliminate newborn HIV infections while minimizing distress, stigma, and discrimination.

24 September 2018 in Journal of Communicable Diseases
Verified
Journal Article
Open access
PDF file
AMAnjali Modi
Anjali Modi
KVKeshav G Vaishnav
Keshav G Vaishnav
RPRupal C Pandya
Rupal C Pandya
GSGanesh C Sahu
Ganesh C Sahu
ANAshish Naik
Ashish Naik
Urban Dengue Surveillance over Sixteen Years: Integration, Trend Analysis and Participation of Private Medical Sector

1 July 2023 in NMO Journal
Verified
Journal Article
Open access
AMAnjali Modi
Anjali Modi
RPRhythm Panchani
Rhythm Panchani
BMBhautik Modi
Bhautik Modi
AAArvind Asthana
Arvind Asthana
The epidemiological transition is a global shift from communicable diseases to non-communicable diseases and injuries, impacting health and demographic indicators. The four-stage demographic transition model illustrates the evolution of population dynamics, with the epidemiological transition model overlaying disease patterns. Egypt-born demographer Omran classified transitions into “Classic,” “Accelerated,” and “Delayed” models, emphasizing the interplay between mortality decline, fertility, and healthcare demands. The Global Burden of Disease (GBD) assesses causes of deaths, disabilities, and risk factors, revealing a shift from communicable to non-communicable diseases worldwide. In India, a significant portion of the population faces a rising burden of non-communicable diseases, particularly ischemic heart disease, chronic obstructive pulmonary disease, and stroke. Health transitions in diseases, demography, donor assistance, and domestic financing in India have implications for the healthcare system. Epidemiological transition levels (ETL) vary across states, affecting vulnerable populations like the elderly and urban women. Challenges arise from a double burden of disease, emphasizing the need for comprehensive policies, awareness, and improved accessibility. Risk factors like malnutrition, air pollution, and high blood pressure contribute to the disease burden. It is concluded by advocating for tailored interventions, utilizing the socio-ecological model, and emphasizing the importance of ongoing research in addressing emerging health challenges.